z-logo
open-access-imgOpen Access
ABCG2, CD44 and SOX9 are increased with the acquisition of drug resistance and involved in cancer stem cell activities in head and neck squamous cell carcinoma cells
Author(s) -
K. Murakami,
Naoki Umemura,
Makoto Adachi,
Masahiro Motoki,
Emika Ohkoshi
Publication year - 2022
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2022.11658
Subject(s) - cancer stem cell , cd44 , stem cell , stem cell marker , abcg2 , biology , head and neck squamous cell carcinoma , cancer research , cancer cell , cisplatin , cancer , side population , cell , microbiology and biotechnology , head and neck cancer , atp binding cassette transporter , chemotherapy , biochemistry , genetics , transporter , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom